Investors’ Chronicle: Lloyds Banking Group,…
BUY: GSK (GSK)Sceptics will say the pipeline leaves much to be desired, but there’s no denying the…
Browsing Tag
GSK
GSK raises forecasts after strong sales in…
Receive free GSK PLC updatesWe’ll send you a myFT Daily Digest email rounding up the latest GSK PLCnews every…
Malaria Vaccines Are Finally Here: The Top Shots…
While researchers have spent decades searching for malaria vaccines, only two have ever been authorized, a…
GSK reaches first legal settlement over…
Receive free GSK PLC updatesWe’ll send you a myFT Daily Digest email rounding up the latest GSK PLCnews every…
FDA Approves Pfizer’s RSV Vaccine For Older…
Topline
The Food and Drug Administration on Wednesday approved Pfizer’s vaccine to protect older adults from RSV,…
RSV Vaccine: FDA Advisors Recommend Pfizer Shot…
Topline
A panel of independent experts on Thursday recommended the Food and Drug Administration approve an RSV…
GSK sales fall after demand for Covid treatment…
GSK beat expectations on revenue and earnings in the first quarter, despite a drop in sales of the Covid-19…
GSK struggles to make investors believe its…
The UK’s two biggest listed drugmakers both celebrated a strong start to 2023 this week and confirmed their…
GSK Inks $2 Billion For Cough Medicine Biotech…
Topline
Pharma giant GlaxoSmithKline on Tuesday announced a deal to buy Canadian biotech Bellus Health for $2…
GSK bets on cough drug with $2bn deal for…
GSK has agreed to buy Canadian biotech Bellus Health in a $2bn deal, its largest acquisition since the UK…